$AFCG

TANNENBAUM LEONARD M purchased $121K of AFCG

TANNENBAUM LEONARD M purchased 35,000 shares of Advanced Flower Capital Inc. (AFCG) at $3.46 ($0.12M total) on 2026-09-10.

Original reporting
SEC EDGAR · TANNENBAUM LEONARD M
Published Sep 11, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AFCG
Neutral
high confidence
Mentioned
$AFCG
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFCGNeutralLow
01

Why it matters

The purchase adds to the director's stake but is modest in dollar terms; likely no immediate price reaction.

02

Market read

Low relevance; the filing is a routine insider purchase with limited market impact.

03

What to watch

If the director is accumulating ahead of a pending corporate event, the purchase could gain relevance.

Relevance 5/10Novelty 5/10Timing: same-day filing

Background

SEC Form 4 filings disclose insider transactions; they are primary sources for insider activity.

Company-level read

Ticker impact

$AFCGNeutralHigh confidence
Context

Director Leonard Tannenbaum purchased 35,000 shares of Advanced Flower Capital Inc. for $121,100 on 2026-09-10, increasing his holdings to 6,884,299 shares.

Expected impact

minimal impact, price likely unchanged

Evidence & confidence

The transaction size ($121k) is modest for a director of a micro‑cap; markets typically view such purchases as low‑signal.

Market effects

None; the filing pertains only to the company itself.

None; no broader regional effect.

None; limited to the issuer.

Counterpoint

Even small insider buys can signal confidence; watch for subsequent buying pressure.

Key entities

  • Leonard Tannenbaum

    Director and 10% owner of Advanced Flower Capital Inc.

  • Advanced Flower Capital Inc.

    Issuer of the securities traded.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFCGMed

Advanced Flower Capital (AFCG) Q2 2026 Earnings Call Transcript

Advanced Flower Capital (AFCG) reported Q2 2026 net investment income of $3.5M, or $0.15 per share, with NAV per share rising to $8.25. The company repurchased 839,406 shares and has a $1.3B investment pipeline. Management highlighted rising default rates in private credit and challenges in the cannabis industry. AFCG is resolving nonaccrual loans and focusing on lower middle market borrowers.

$AFCGMed

Advanced Flower Capital Inc. (AFCG): Results of Operations and Financial Condition

Advanced Flower Capital Inc. (AFCG) filed an SEC Form 8-K — Results of Operations and Financial Condition. AFC Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net investment income (“NII”) of $3.5 million, or $0.15 per weighted average share WEST PALM BEACH, FL, August 13, 2026 – Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) tod

$AFCGMed

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) said it committed $7.0 million to a $25.0 million senior secured credit facility, including a term loan and delayed draw term loan. An AFC affiliate will add $5.0 million, for $12.0 million total. Proceeds will refinance existing capital and fund acquisitions for an outpatient behavioral health platform. The facility has a four-year term.